PHVS

Pharvaris is a drug development company working on treatments for rare swelling disorders. The company is testing a medication called deucrictibant that is designed to treat and prevent attacks of hereditary angioedema, a condition where patients experience dangerous swelling in the face, throat, and other parts of the body. The company is in late-stage testing of this drug, with versions in both pill and capsule form. Pharvaris was founded in 2015 and is based in Switzerland.